2022
Thematic series
The SDGs for management of related problems in renal replacement therapy
2019
Thematic series
Official Guideline and Registry Data of Renal Replacement Therapy
Renal Replacement Therapy is a peer-reviewed journal facilitating worldwide discussion of research and issues related to the study of renal replacement therapy.
RRT considers articles on all aspects of hemodialysis, peritoneal dialysis, blood purification, renal transplantation and regenerative medicine. In addition, the journal publishes content in wider fields such as chronic kidney disease (CKD), acute kidney injury (AKI), critical care medicine and intensive care, bone and mineral metabolism, anemia and iron metabolism, infection, cardiac disease, cerebral disease, diabetes mellitus, hypertension, nutrition, and related social issues. Contributions are encouraged from a global perspective across many disciplines.
2022
Thematic series
The SDGs for management of related problems in renal replacement therapy
2019
Thematic series
Official Guideline and Registry Data of Renal Replacement Therapy
The 15th Annual Meeting of the Japanese Society of Renal Rehabilitation
15-16 March 2025, Pacifico Yokohama
The 70th Annual Meeting of the Japanese Society for Dialysis Therapy
27-29 June 2025, Osaka International Convention Center
The 36th Annual Meeting of the Japan Society for Blood Purification Critical Care
20-21 September 2025, Ochanomizu Sola City Conference Center
The 19th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
1-2 November 2025, Toranomon Hills Forum
The 31th Annual Meeting of the Japanese Society for the Peritoneal Dialysis Therapy
22-23 November 2025, Toranomon Hills Forum
The 28th Annual Meeting of the Japan Academy of Nephrology Nursing
29-30 November 2025, Kobe Convention Center
The 46th Annual Meeting of the Japanese Society for Pediatric Renal Failure
18-19 December 2025, Yumoto Fujiya Hotel
The 59th Annual Meeting of the Japanese Society for Clinical Renal Transplantation
12-14 February 2026
The 16th Annual Meeting of the Japanese Society of Renal Rehabilitation
14-15 March 2026, KURUME City Plaza
The 71th Annual Meeting of the Japanese Society for Dialysis Therapy
19-21 June 2026, Kobe Convention Center
The 37th Annual Meeting of the Japan Society for Blood Purification Critical Care
12-13 September 2026, SAGA Arena
The 20th Annual Meeting of the Japanese Society of Nephrology and Pharmacotherapy
31 October -1 November 2026, Osaka International Convention Center
The 29th Annual Meeting of the Japan Academy of Nephrology Nursing
21-22 November 2026, Grand Mercure SAPPORO Ohdori Park
The 72th Annual Meeting of the Japanese Society for Dialysis Therapy
28-30 May 2027, Tokyo International Forum
Please use the online submission system to submit your manuscript. For all enquiries about the journal, please access the site and click Contact Us.
Renal Replacement Therapy is the official publication of the following societies:
This study examined the effects of percutaneous coronary intervention (PCI) on intradialytic hypotension (IDH) in dialysis patients. It found that PCI significantly reduced IDH risk within the first 90 days post-procedure, particularly in patients with diabetes, while no significant reduction was observed between 91–180 days. These findings highlight PCI’s potential benefits in managing IDH among high-risk patients, warranting further investigation.
This study explored urine NGAL levels as a biomarker for acute kidney injury (AKI) in patients with brain death due to traumatic brain injury (TBI). It found that urine NGAL levels increased significantly over time and showed excellent predictive value for AKI, correlating positively with kidney damage scores. These findings highlight urine NGAL as a promising tool for early kidney injury detection in potential organ donors.
This study investigated the cytokine adsorption characteristics in continuous kidney replacement therapy (CKRT) with cytokine adsorbing hemofilters (CAH) under low-convection volume settings. It found that creatinine clearance increased with flow rate, but cytokine adsorption (IL-6 and IL-8) was not affected by filtration flow rate, regardless of the membrane type. These findings highlight limitations in filtration flow rate for cytokine clearance in CAH-CKRT.
See this article:
This featured collection explores advancements in kidney transplantation amid rising end-stage renal disease (ESRD) cases. While human-to-human kidney allotransplantation is a key medical treatment, donor availability remains a major hurdle. The potential of swine-to-human xenotransplantation presents new possibilities but also introduces challenges like immune response-induced rejection and tissue damage.
The 67th Annual Meeting of the Japanese Society for Dialysis Therapy was held in June 2022, under the theme “Seeking SDGs for Dialysis Therapy.” The main goal of this conference was to identify sustainable goals for dialysis treatment and consider the best means of achieving them.
In commemoration of the success of the meeting, we are pleased to announce that the article collection entitled “The SDGs for management of related problems in renal replacement therapy” has now published in the spring of 2023.
In this article collection, we invited nine leading researchers to reaffirm our commitment to identifying the various problems and to achieving these goals through sustained efforts.
Renal Replacement Therapy publishes valuable data based on clinical practice guidelines, statistical surveys, and epidemiological studies. This collection offers easy access to these resources. All papers in the collection are frequently accessed and highly cited. Moreover, the full text is published free of charge using an open journal CC-BY format. By pursuing this approach, our goal is to contribute as much as possible to the renal replacement therapy community while also responding to your interests.
The outbreak of novel coronavirus disease 2019 (COVID-19) led to a worldwide pandemic. Both failure to recover and poor prognoses for COVID-19 have been reported in patients with end-stage renal disease (ESRD) treated with renal replacement therapy and in the elderly. ESRD patients in Japan are one of the oldest populations in the world. Accordingly, we decided to launch the special collection on COVID-19 in RRT, the official journal of several academic societies with a focus on renal replacement therapy. We hope that this collection will support you in your own efforts.
Dr. Takashi Shigematsu, Editor-in-Chief
Dr. Takashi Shigematsu is currently the emeritus professor of the department of nephrology at the Wakayama Medical University School of Medicine, Japan. He is now actively working as Director of Division of Nephrology and Clinical Research Center in Rinku General Medical Center. He is also a member of the International Society of Nephrology and the American Society of Nephrology.
His research interests focus on Mineral and Bone Disorder associated with chronic kidney disease (CKD) including vascular calcification, Senescence. Renal Anemia is another his major interest. In addition, he has been investigating and working in the fields of hemodialysis and vascular access, peritoneal dialysis, blood purification medicine in acute kidney injury, and kidney transplantation.
Prof. Masanori Abe, Deputy Editor
Professor and Chair of the Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
Prof. Abe also serves as the Chief Director of Blood Purification Center of Nihon University Itabashi Hospital. His professional interests include Nephrology and Renal Replacement Therapy.
If your manuscript could benefit from improvements to the English language, you should have your manuscript reviewed by someone who is fluent in English. For a collection of free resources to help with writing in English please visit here. If you would like professional help, we recommend our affiliates Nature Research Editing Service and American Journal Experts for help with English usage. BMC authors receive 10% off their first submission to either service. Please note that use of an editing service is neither a requirement nor a guarantee of publication.
Citation Impact 2023
Journal Impact Factor: 0.9
5-year Journal Impact Factor: N/A
Source Normalized Impact per Paper (SNIP): 0.530
SCImago Journal Rank (SJR): 0.315
Speed 2024
Submission to first editorial decision (median days): 10
Submission to acceptance (median days): 133
Usage 2024
Downloads: 430,721
Altmetric mentions: 116